Search research articles
Contact Us
Filters
Showing results (391-400 of 547) with videos related to
Page
of 55
Sort By:
Plos One
|
September 24, 2013
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study
Michelle M Mielke, Walter Maetzler, Norman J Haughey, et al.
Journal of Neurology
|
March 20, 2012
Long-term follow-up of subthalamic nucleus stimulation in glucocerebrosidase-associated Parkinson's disease
Daniel Weiss, Kathrin Brockmann, Karin Srulijes, et al.
Journal of Alzheimer'S Disease : JAD
|
March 23, 2016
Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus
Benjamin Roeben, Walter Maetzler, Eugeen Vanmechelen, et al.
Orphanet Journal of Rare Diseases
|
February 29, 2020
Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation
Claire Cannet, Andrea Pilotto, Júlio César Rocha, et al.
The Lancet. Neurology
|
April 16, 2013
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
Daniela Berg, Anthony E Lang, Ronald B Postuma, et al.
Frontiers in Aging Neuroscience
|
March 23, 2017
Associations between Early Markers of Parkinson's Disease and Sarcopenia
Michael Drey, Sandra E Hasmann, Jan-Peter Krenovsky, et al.
Plos One
|
September 23, 2015
Age and Vascular Burden Determinants of Cortical Hemodynamics Underlying Verbal Fluency
Sebastian Heinzel, Florian G Metzger, Ann-Christine Ehlis, et al.
Acta Neuropathologica
|
November 8, 2014
In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody
Walter Maetzler, Andrea Pilotto, Anja Apel, et al.
Journal of Neurology
|
April 27, 2021
Memory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial
Nele Schmidt, Inken Tödt, Daniela Berg, et al.
Frontiers in Aging Neuroscience
|
April 20, 2017
Evidence for a Selectively Regulated Prioritization Shift Depending on Walking Situations in Older Adults
Dina Salkovic, Markus A Hobert, Carolin Bellut, et al.
Page
of 55
Search research articles
Search
Showing results (391-400 of 547) with videos related to
Sort By:
Page
of 55
Plos One
|
September 24, 2013
Plasma ceramide and glucosylceramide metabolism is altered in sporadic Parkinson's disease and associated with cognitive impairment: a pilot study
Michelle M Mielke, Walter Maetzler, Norman J Haughey, et al.
Journal of Neurology
|
March 20, 2012
Long-term follow-up of subthalamic nucleus stimulation in glucocerebrosidase-associated Parkinson's disease
Daniel Weiss, Kathrin Brockmann, Karin Srulijes, et al.
Journal of Alzheimer'S Disease : JAD
|
March 23, 2016
Association of Plasma Aβ40 Peptides, But Not Aβ42, with Coronary Artery Disease and Diabetes Mellitus
Benjamin Roeben, Walter Maetzler, Eugeen Vanmechelen, et al.
Orphanet Journal of Rare Diseases
|
February 29, 2020
Lower plasma cholesterol, LDL-cholesterol and LDL-lipoprotein subclasses in adult phenylketonuria (PKU) patients compared to healthy controls: results of NMR metabolomics investigation
Claire Cannet, Andrea Pilotto, Júlio César Rocha, et al.
The Lancet. Neurology
|
April 16, 2013
Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities
Daniela Berg, Anthony E Lang, Ronald B Postuma, et al.
Frontiers in Aging Neuroscience
|
March 23, 2017
Associations between Early Markers of Parkinson's Disease and Sarcopenia
Michael Drey, Sandra E Hasmann, Jan-Peter Krenovsky, et al.
Plos One
|
September 23, 2015
Age and Vascular Burden Determinants of Cortical Hemodynamics Underlying Verbal Fluency
Sebastian Heinzel, Florian G Metzger, Ann-Christine Ehlis, et al.
Acta Neuropathologica
|
November 8, 2014
In vivo markers of Parkinson's disease and dementia with Lewy bodies: current value of the 5G4 α-synuclein antibody
Walter Maetzler, Andrea Pilotto, Anja Apel, et al.
Journal of Neurology
|
April 27, 2021
Memory enhancement by multidomain group cognitive training in patients with Parkinson's disease and mild cognitive impairment: long-term effects of a multicenter randomized controlled trial
Nele Schmidt, Inken Tödt, Daniela Berg, et al.
Frontiers in Aging Neuroscience
|
April 20, 2017
Evidence for a Selectively Regulated Prioritization Shift Depending on Walking Situations in Older Adults
Dina Salkovic, Markus A Hobert, Carolin Bellut, et al.
Page
of 55